stockportfolio.pro
Cytokinetics, Incorporated Shares Outstanding 1999–2025
Cytokinetics, Incorporated (CYTK) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 122.9M | +4.0% |
| FY 2024 | 118.2M | +16.3% |
| FY 2023 | 101.6M | +7.2% |
| FY 2022 | 94.8M | +11.8% |
| FY 2021 | 84.8M | +19.4% |
| FY 2020 | 71.0M | +20.0% |
| FY 2019 | 59.2M | +8.1% |
| FY 2018 | 54.7M | +1.4% |
| FY 2017 | 54.0M | +32.8% |
| FY 2016 | 40.6M | +2.7% |
| FY 2015 | 39.6M | +2.4% |
| FY 2014 | 38.7M | +26.0% |
| FY 2013 | 30.7M | +29.2% |
| FY 2012 | 23.7M | +90.2% |
| FY 2011 | 12.5M | +12.0% |
| FY 2010 | 11.2M | — |
| FY 2009 | 0.0M | — |
| FY 2008 | 0.0M | — |
| FY 2007 | 0.0M | — |
| FY 2006 | 0.0M | — |
| FY 2005 | 0.0M | — |
| FY 2004 | 0.0M | — |
| FY 2003 | 0.0M | — |
| FY 2002 | 0.0M | — |
| FY 2001 | 0.0M | — |
| FY 2000 | 0.0M | — |
| FY 1999 | 0.0M | — |
Source: Cytokinetics, Incorporated SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Cytokinetics, Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCytokinetics, Incorporated — frequently asked questions
What is Cytokinetics, Incorporated's shares outstanding?
Cytokinetics, Incorporated (CYTK) reported shares outstanding of 122.9M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Cytokinetics, Incorporated's official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.